BALATON and COMINO: Phase III Randomized Clinical Trials of Faricimab for Retinal Vein Occlusion: Study Design and Rationale;
Hattenbach, LO, Abreu, F, Arrisi, P, Basu, K, Danzig, CJ, Guymer, R, Haskova, Z, Heier, JS, Kotecha, A, Liu, Y, Loewenstein, A, Seres, A, Willis, JR, Wykoff, CC & Paris, LP 2023, , Ophthalmology Science, vol. 3, no. 3, 100302.

Dynamic visual acuity as a biometric for astronaut performance and safety;
Waisberg, E, Ong, J, Paladugu, P, Kamran, SA, Zaman, N, Lee, AG & Tavakkoli, A 2023, , Life Sciences in Space Research, vol. 37, pp. 3-6.

Evolution of benign episodic pupillary dilation to Adie's tonic pupil;
Noubani, L, Hummel, L, Pakravan, M, Charoenkijkajorn, C & Lee, AG 2023, , Canadian Journal of Ophthalmology, vol. 58, no. 2, pp. e87-e88.

Junctional visual field loss: a reappraisal of nomenclature;
Chopra, J, Arismendez, A, Mahajan, J, Vickers, A & Lee, AG 2023, , Canadian Journal of Ophthalmology, vol. 58, no. 2, pp. e84-e87.

Impact of retinal fluid-free months on outcomes in neovascular age-related macular degeneration: A treatment agnostic analysis of the hawk and harrier studies;
Eichenbaum, D, Brown, DM, Ip, M, Khanani, AM, Figueroa, MS, McAllister, IL, Laude, A, Uruprasad, B, Tang, S, Gmeiner, B, Clemens, A & Souied, E 2023, , Retina, vol. 43, no. 4, pp. 632-640.

Optical Coherence Tomography Biomarkers for Conversion to Exudative Neovascular Age-related Macular Degeneration;
Wakatsuki, Y, Hirabayashi, K, Yu, HJ, Marion, KM, Corradetti, G, Wykoff, CC & Sadda, SR 2023, , American Journal of Ophthalmology, vol. 247, pp. 137-144.

Posterior Reversible Encephalopathy Syndrome in a Patient with Primary Hyperaldosteronism (Conn Syndrome);
Ali, A, Raviskanthan, S, Mortensen, PW & Lee, AG 2023, , Journal of Neuro-Ophthalmology, vol. 43, no. 1, pp. E9-E11.

Morphological characteristics of eyes with neovascular age-related macular degeneration and good long-term visual outcomes after anti-VEGF therapy;
Fang, M, Chanwimol, K, Maram, J, Datoo OKeefe, GA, Wykoff, CC, Sarraf, D, Brown, A, Lampen, SIR, Zhou, B, Rusakevich, AM & Sadda, SV 2023, , British Journal of Ophthalmology, vol. 107, no. 3, pp. 399-405.

Outcomes of Patients With Thyroid Eye Disease Partially Treated With Teprotumumab;
Ho, TC, Maamari, RN, Kossler, AL, Sears, CM, Freitag, SK, Reshef, ER, Shinder, R, Rootman, DB, Diniz, SB, Kahana, A, Schlachter, D, Do, TH, Kally, P, Turner, S, Mokhtarzadeh, A, Harrison, AR, Hwang, CJ, Kim, HJ, Avila, SA, Thomas, DA, Magazin, M, Wester, ST, Lee, WW, Clauss, KD, Holds, JB, Sniegowski, M, Compton, CJ, Briggs, C, Malik, AI, Lucarelli, MJ, Burkat, CN, Patel, LG & Couch, SM 2023, , Ophthalmic Plastic and Reconstructive Surgery, vol. 39, no. 2, pp. 150-155.